Preparation, Characterization and Antimicrobial Studies of Cu (II) and Mn (II) Complexes with Schiff Base Derivedfrom Benzaldehyde and2,4-Dinitrophenylhydrazine

Autor: A. Baffa, A.N Panda, S.D Sardo, A.A Muhammad, Yahaya sa`idu, A. Abdulmalik, S. S. Bashir

Publikováno v: International Journal of Advances in Scientific Research and Engineering. :88-92

Two series of Cu(II) and Mn(II) complexes were prepared by refluxing ethanolic solution of their salts with Schiff base obtained from benzaldehyde and 2,4-dinitrophenylhydrazine into a 1:2 ratio. The prepared compounds were characterized by solubilit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2726bc9087da444eb946eca5da5b7552
https://doi.org/10.31695/ijasre.2021.34017

Social determinants of health inequalities in early phase clinical trials in Northern England.

Autor: Rae S; Sir Bobby Robson Cancer Trials Research Centre, Northern Centre for Cancer Care, Freeman Hospital, Freeman Road, Newcastle upon Tyne, NE7 7DN, UK. sarah.rae2@newcastle.ac.uk.; Newcastle University, Newcastle upon Tyne, NE1 7RU, UK. sarah.rae2@newcastle.ac.uk., Shaya S; The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK., Taylor E; Sir Bobby Robson Cancer Trials Research Centre, Northern Centre for Cancer Care, Freeman Hospital, Freeman Road, Newcastle upon Tyne, NE7 7DN, UK., Hoben J; Sir Bobby Robson Cancer Trials Research Centre, Northern Centre for Cancer Care, Freeman Hospital, Freeman Road, Newcastle upon Tyne, NE7 7DN, UK., Oluwashegun D; Newcastle University, Newcastle upon Tyne, NE1 7RU, UK., Lowe H; Sir Bobby Robson Cancer Trials Research Centre, Northern Centre for Cancer Care, Freeman Hospital, Freeman Road, Newcastle upon Tyne, NE7 7DN, UK., Haris N; Sir Bobby Robson Cancer Trials Research Centre, Northern Centre for Cancer Care, Freeman Hospital, Freeman Road, Newcastle upon Tyne, NE7 7DN, UK., Bashir S; Sir Bobby Robson Cancer Trials Research Centre, Northern Centre for Cancer Care, Freeman Hospital, Freeman Road, Newcastle upon Tyne, NE7 7DN, UK., Oing C; Sir Bobby Robson Cancer Trials Research Centre, Northern Centre for Cancer Care, Freeman Hospital, Freeman Road, Newcastle upon Tyne, NE7 7DN, UK.; Newcastle University, Newcastle upon Tyne, NE1 7RU, UK., Krebs MG; The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK.; University of Manchester, Oxford Road, Manchester, M13 9PL, UK., Thistlethwaite FC; The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK.; University of Manchester, Oxford Road, Manchester, M13 9PL, UK., Carter L; The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK.; University of Manchester, Oxford Road, Manchester, M13 9PL, UK., Cook N; The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK.; University of Manchester, Oxford Road, Manchester, M13 9PL, UK., Greystoke A; Sir Bobby Robson Cancer Trials Research Centre, Northern Centre for Cancer Care, Freeman Hospital, Freeman Road, Newcastle upon Tyne, NE7 7DN, UK.; Newcastle University, Newcastle upon Tyne, NE1 7RU, UK., Graham DM; The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK.; University of Manchester, Oxford Road, Manchester, M13 9PL, UK., Plummer R; Sir Bobby Robson Cancer Trials Research Centre, Northern Centre for Cancer Care, Freeman Hospital, Freeman Road, Newcastle upon Tyne, NE7 7DN, UK.; Newcastle University, Newcastle upon Tyne, NE1 7RU, UK.

Publikováno v: British journal of cancer [Br J Cancer] 2024 Sep; Vol. 131 (4), pp. 685-691. Date of Electronic Publication: 2024 Jun 24.

Study protocol: a pragmatic, cluster-randomized controlled trial to evaluate the effect of implementation of the Truenat platform/MTB assays at primary health care clinics in Mozambique and Tanzania (TB-CAPT CORE).

Autor: Leukes VN; FIND, Geneva, Switzerland., Hella J; Ifakara Health Institute, Dar Es Salaam, Tanzania., Sabi I; Mbeya Medical Research Centre, National Institute for Medical Research (NIMR), Mbeya, Tanzania., Cossa M; Centro de Investigação Em Saúde de Manhiça (CISM), Manhica, Mozambique., Khosa C; Instituto Nacional de Saúde (INS), Marracuene, Mozambique., Erkosar B; FIND, Geneva, Switzerland., Mangu C; Mbeya Medical Research Centre, National Institute for Medical Research (NIMR), Mbeya, Tanzania., Siyame E; Mbeya Medical Research Centre, National Institute for Medical Research (NIMR), Mbeya, Tanzania., Mtafya B; Mbeya Medical Research Centre, National Institute for Medical Research (NIMR), Mbeya, Tanzania., Lwilla A; Mbeya Medical Research Centre, National Institute for Medical Research (NIMR), Mbeya, Tanzania., Viegas S; Instituto Nacional de Saúde (INS), Marracuene, Mozambique., Madeira C; Instituto Nacional de Saúde (INS), Marracuene, Mozambique., Machiana A; Instituto Nacional de Saúde (INS), Marracuene, Mozambique., Ribeiro J; Instituto Nacional de Saúde (INS), Marracuene, Mozambique., Garcia-Basteiro AL; Centro de Investigação Em Saúde de Manhiça (CISM), Manhica, Mozambique.; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain., Riess F; Division of Infectious Diseases and Tropical Medicine, Ludwig Maximilian University Hospital, Munich, Germany., Elísio D; Centro de Investigação Em Saúde de Manhiça (CISM), Manhica, Mozambique., Sasamalo M; Ifakara Health Institute, Dar Es Salaam, Tanzania., Mhalu G; Ifakara Health Institute, Dar Es Salaam, Tanzania., Denkinger CM; Division of Infectious Disease and Tropical Medicine and German Centre for Infection Research, Heidelberg University Hospital, Heidelberg, Germany., Castro MDM; Division of Infectious Disease and Tropical Medicine and German Centre for Infection Research, Heidelberg University Hospital, Heidelberg, Germany., Bashir S; Division of Infectious Disease and Tropical Medicine and German Centre for Infection Research, Heidelberg University Hospital, Heidelberg, Germany., Schumacher SG; FIND, Geneva, Switzerland., Tagliani E; Emerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy., Malhotra A; Johns Hopkins University (JHU), Baltimore, MD, USA., Dowdy D; Johns Hopkins University (JHU), Baltimore, MD, USA., Schacht C; LINQ Management, Berlin, Germany., Buech J; LINQ Management, Berlin, Germany., Nguenha D; Centro de Investigação Em Saúde de Manhiça (CISM), Manhica, Mozambique., Ntinginya N; Mbeya Medical Research Centre, National Institute for Medical Research (NIMR), Mbeya, Tanzania., Ruhwald M; FIND, Geneva, Switzerland., Penn-Nicholson A; FIND, Geneva, Switzerland. Adam.penn-nicholson@finddx.org., Kranzer K; Division of Infectious Diseases and Tropical Medicine, Ludwig Maximilian University Hospital, Munich, Germany. Katharina.kranzer@lshtm.ac.uk.; Clinical Research Department, London School of Hygiene and Tropical Medicine, London, UK. Katharina.kranzer@lshtm.ac.uk.

Publikováno v: BMC infectious diseases [BMC Infect Dis] 2024 Jan 19; Vol. 24 (1), pp. 107. Date of Electronic Publication: 2024 Jan 19.

First-Pass Effect in M1-Occlusion Stroke Patients Treated with Combined Stent-Retriever/Large-Bore Distal Aspiration Catheter Thrombectomy.

Autor: Remollo S; Interventional Neuroradiology Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Werner M; Interventional Neuroradiology Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Blasco J; Neurointerventional Department CDI, Hospital Clinic of Barcelona, Barcelona, Spain., López-Rueda A; Neurointerventional Department CDI, Hospital Clinic of Barcelona, Barcelona, Spain., San Roman L; Neurointerventional Department CDI, Hospital Clinic of Barcelona, Barcelona, Spain., Jimenez-Gomez E; Diagnostic and Therapeutical Neuroradiology Unit, Hospital Universitario Reina Sofía, Córdoba, Spain., Bravo Rey I; Neuroradiology Department, Hospital Universitario Reina Sofia, Córdoba, Spain., Vega P; Radiology Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Murias E; Radiology Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Rosati S; Neurointerventional Unit, Hospital Clinico Universitario San Carlos, Madrid, Spain., Pérez-García C; Neurointerventional Unit, Hospital Clinico Universitario San Carlos, Madrid, Spain., González E; Interventional Neuroradiology, Radiology Department, Cruces University Hospital, Barakaldo, Spain., Manso X; Interventional Neuroradiology, Radiology Department, Cruces University Hospital, Barakaldo, Spain., Aixut S; Neuroradiology Department, Hospital Universitari de Bellvitge, l'Hospitalet de Llobregat, Llobregat, Spain., Chirife Chaparro O; Neuroradiology Department, Hospital Universitari de Bellvitge, l'Hospitalet de Llobregat, Llobregat, Spain., Terceño M; Stroke Unit, Department of Neurology, Hospital Universitari de Girona Doctor Josep Trueta, Girona, Spain., Bashir S; Stroke Unit, Department of Neurology, Hospital Universitari de Girona Doctor Josep Trueta, Girona, Spain., Pumar JM; Neuroradiology Department, Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain., Ruiz-González E; Interventional Neuroradiology, Hospital General Universitario de Alicante, Alicante, Spain., Méndez JC; Interventional Neuroradiology, Hospital Universitario Ramon y Cajal, Madrid, Spain., Aguilar Tejedor Y; Radiology Department, Hospital Universitario Insular de Gran Canaria, Gran Canaria, Spain., Zamarro J; Interventional Neuroradiology, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain., Castaño M; Interventional Neuroradiology Unit, Department of Radiology, Hospital Universitario de Salamanca, Salamanca, Spain., Daunis-I-Estadella P; Department of Computer Science, Applied Mathematics and Statistics, University of Girona, Girona, Spain., Puig J; Department of Radiology (IDI) and Institut d'Investigació Biomèdica de Girona, Hospital Universitari Doctor Josep Trueta, Girona, Spain. jpuigmd@gmail.com.

Publikováno v: Clinical neuroradiology [Clin Neuroradiol] 2023 Sep; Vol. 33 (3), pp. 701-708. Date of Electronic Publication: 2023 Mar 01.

Author Correction: Inhibitory potential of triazines and hydrazinyl thiazole substituted chromones against the HslVU protease/chaperone complex, a novel drug target.

Autor: Hamid M; Department of Biochemistry, University of Karachi, Karachi, Pakistan., Aurangzeb S, Rashid Y, Shamim S, Salar U, Azim MK, Khan KM, Bashir S

Publikováno v: European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] 2022 Dec; Vol. 26 (24), pp. 9061.